• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年患者低维生素B12水平经口服钴胺素治疗一周内治愈

[Low vitamin B12 levels in elderly patients cured within one week by oral cobalamin therapy].

作者信息

Kaltenbach G, Andrès E, Barnier-Figue G, Noblet-Dick M, Noël E, Vogel T, Perrin A E, Berthel M

机构信息

Centre de gérontologie, Hôpital de la Robertsau, Strasbourg.

出版信息

Presse Med. 2005 Mar 12;34(5):358-62.

PMID:15859569
Abstract

OBJECTIVE

Non-dissociation of vitamin B12 from its carrying proteins is the most frequent cause of vitamin B12 deficiency in the elderly. The aim of this study was to determine the initial dose of oral cyanocobalamin that would correct the B12 vitamin deficiency within one week.

METHODS

This was an open, prospective, study on 30 elderly patients suffering from vitamin deficiency (B12 < 0.20 microg/L) induced by food-cobalamin malabsorption. Ten patients (group I) were treated with a daily dose of 1000 microg of oral cyanocobalamin (from D1 to D8), 10 (group II) with 1000 microg every other day (D1, D3, D5 and D7), 5 (group III) with 1000 microg every 4 days (D1 and D5) and 5 (group IV) with 1000 microg only on D1. The biological response was assessed by control measurement of vitamin B12 serum levels on the 8th day.

RESULTS

Mean vitamin B12 serum levels had significantly increased (p < 0.01) in groups I, II and III, but not in group IV. The dose-effect, assessed by the mean increase in vitamin B12 serum levels, was significantly greater (p < 0.05) in groups I (0.25 microg/L) and II (0.18 microg/L), than in groups III and IV (0.09 microg/L).

CONCLUSION

This prospective study shows that an oral dose of 1000 microg of cyanocobalamin every 4 days, which corresponds to 250 microg per day, was sufficient to correct B12 vitamin deficiency induced by food-cobalamin malabsorption within one week. However, initial doses of 1000 microg per day or every other day would be preferable because of the greater dose-effect with daily doses higher than 500 microg. A randomised study is warranted to validate these preliminary results.

摘要

目的

维生素B12与其运载蛋白不分离是老年人维生素B12缺乏最常见的原因。本研究的目的是确定能在一周内纠正维生素B12缺乏的口服氰钴胺初始剂量。

方法

这是一项针对30例因食物钴胺素吸收不良导致维生素缺乏(维生素B12<0.20μg/L)的老年患者的开放性前瞻性研究。10例患者(I组)每天口服1000μg氰钴胺(从第1天至第8天),10例(II组)每隔一天口服1000μg(第1、3、5和7天),5例(III组)每4天口服1000μg(第1和5天),5例(IV组)仅在第1天口服1000μg。通过在第8天对照测量维生素B12血清水平来评估生物学反应。

结果

I、II和III组的维生素B12血清平均水平显著升高(p<0.01),而IV组未升高。通过维生素B12血清水平的平均升高评估的剂量效应,I组(0.25μg/L)和II组(0.18μg/L)显著大于III组和IV组(0.09μg/L)(p<0.05)。

结论

这项前瞻性研究表明,每4天口服1000μg氰钴胺,相当于每天250μg,足以在一周内纠正食物钴胺素吸收不良引起的维生素B12缺乏。然而,由于每日剂量高于500μg时剂量效应更大,每天或每隔一天1000μg的初始剂量可能更可取。有必要进行一项随机研究来验证这些初步结果。

相似文献

1
[Low vitamin B12 levels in elderly patients cured within one week by oral cobalamin therapy].老年患者低维生素B12水平经口服钴胺素治疗一周内治愈
Presse Med. 2005 Mar 12;34(5):358-62.
2
A randomized, double-blind, placebo-controlled study of oral vitamin B12 supplementation in older patients with subnormal or borderline serum vitamin B12 concentrations.一项针对血清维生素B12浓度低于正常或处于临界值的老年患者口服补充维生素B12的随机、双盲、安慰剂对照研究。
J Am Geriatr Soc. 2002 Jan;50(1):146-51. doi: 10.1046/j.1532-5415.2002.50020.x.
3
Hematological response to short-term oral cyanocobalamin therapy for the treatment of cobalamin deficiencies in elderly patients.短期口服氰钴胺素治疗老年患者钴胺素缺乏症的血液学反应。
J Nutr Health Aging. 2006 Jan-Feb;10(1):3-6.
4
Effect of 8-week oral supplementation with 3-µg cyano-B12 or hydroxo-B12 in a vitamin B12-deficient population.维生素 B12 缺乏人群口服 3μg 氰钴胺或羟钴胺 8 周的效果。
Eur J Nutr. 2019 Feb;58(1):261-270. doi: 10.1007/s00394-017-1590-0. Epub 2017 Dec 5.
5
Oral cyanocobalamin supplementation in older people with vitamin B12 deficiency: a dose-finding trial.老年维生素B12缺乏患者口服补充氰钴胺:一项剂量探索试验。
Arch Intern Med. 2005 May 23;165(10):1167-72. doi: 10.1001/archinte.165.10.1167.
6
[Early response to oral cobalamin therapy in older patients with vitamin B12 deficiency].老年维生素B12缺乏患者对口服钴胺素治疗的早期反应
Ann Med Interne (Paris). 2003 Mar;154(2):91-5.
7
Oral versus intramuscular cobalamin treatment in megaloblastic anemia: a single-center, prospective, randomized, open-label study.巨幼细胞贫血的口服与肌内注射钴胺素治疗:一项单中心、前瞻性、随机、开放标签研究。
Clin Ther. 2003 Dec;25(12):3124-34. doi: 10.1016/s0149-2918(03)90096-8.
8
[Oral vitamin B12: Efficacy and safety data in 31 patients with pernicious anemia and food-cobalamin malabsorption].[口服维生素B12:31例恶性贫血和食物钴胺素吸收不良患者的疗效和安全性数据]
Presse Med. 2010 Dec;39(12):e273-9. doi: 10.1016/j.lpm.2010.03.027. Epub 2010 Aug 12.
9
Comparing the efficacy and tolerability of a new daily oral vitamin B12 formulation and intermittent intramuscular vitamin B12 in normalizing low cobalamin levels: a randomized, open-label, parallel-group study.比较新型每日口服维生素 B12 制剂和间歇性肌内注射维生素 B12 对正常化低钴胺素水平的疗效和耐受性:一项随机、开放标签、平行组研究。
Clin Ther. 2011 Mar;33(3):358-371.e2. doi: 10.1016/j.clinthera.2011.03.003.
10
[Effectiveness of oral vitamin B12 therapy for pernicious anemia and vitamin B12 deficiency anemia].口服维生素B12治疗恶性贫血和维生素B12缺乏性贫血的疗效
Rinsho Ketsueki. 2002 Mar;43(3):165-9.